Most Innovative Meetings 2025: Nashville Hematology Conference
The Nashville Hematology Conference brings together top national experts and community practitioners to explore the latest updates and challenges in the management of hematologic malignancies. The 3rd annual event will take place at the Country Music Hall of Fame® and Museum in Nashville, TN, from Thursday, February 18, 2027, to Saturday, February 20, 2027, and is intentionally designed to create a fun, informative, and innovative experience that meaningfully engages both academic and community clinicians.
This anticipated 2-day, CE-accredited conference equips attendees with the knowledge needed to navigate increasingly complex treatment landscapes across hematologic malignancies and manage patients throughout therapy. Attendees will examine current standards of care and evaluate how emerging data may influence treatment algorithms across a range of lymphoid and myeloid diseases.
The conference features engaging lectures on evolving standards of care, management of relapse after initial therapy, the integration of T‑cell redirecting therapies into community practice, and strategies for treating later relapse. Hot topic discussions—spanning healthcare policy, MRD in hematologic malignancies, and ongoing controversies in treatment—will be explored through a community‑focused lens.
Faculty experts will examine and debate treatment options across hematologic malignancies while keeping the unique challenges faced by community practitioners at the forefront. Throughout the conference, attendees can participate in live Q&A sessions and take advantage of numerous networking opportunities and personal discussions. The Nashville Hematology Conference is designed to provide attendees with the practical tools needed to provide the most current, evidence-based care for patients with hematologic malignancies.
Most Innovative Meetings 2025: Nashville Hematology Conference
The Nashville Hematology Conference brings together top national experts and community practitioners to explore the latest updates and challenges in the management of hematologic malignancies. The 3rd annual event will take place at the Country Music Hall of Fame® and Museum in Nashville, TN, from Thursday, February 18, 2027, to Saturday, February 20, 2027, and is intentionally designed to create a fun, informative, and innovative experience that meaningfully engages both academic and community clinicians.
This anticipated 2-day, CE-accredited conference equips attendees with the knowledge needed to navigate increasingly complex treatment landscapes across hematologic malignancies and manage patients throughout therapy. Attendees will examine current standards of care and evaluate how emerging data may influence treatment algorithms across a range of lymphoid and myeloid diseases.
The conference features engaging lectures on evolving standards of care, management of relapse after initial therapy, the integration of T‑cell redirecting therapies into community practice, and strategies for treating later relapse. Hot topic discussions—spanning healthcare policy, MRD in hematologic malignancies, and ongoing controversies in treatment—will be explored through a community‑focused lens.
Faculty experts will examine and debate treatment options across hematologic malignancies while keeping the unique challenges faced by community practitioners at the forefront. Throughout the conference, attendees can participate in live Q&A sessions and take advantage of numerous networking opportunities and personal discussions. The Nashville Hematology Conference is designed to provide attendees with the practical tools needed to provide the most current, evidence-based care for patients with hematologic malignancies.
1. Appropriately apply evidence-based management practices across diverse treatment settings.
2. Integrate best practices regarding T-cell redirecting therapies into practice, including managing acute and long-term potential toxicities.
3. Apply up-to-date prognostic and molecular testing to inform clinical decision-making across the continuum of care.
4. Address challenges of treating hematologic malignancies in patients with unmet needs, including frail patients and disparate populations.
2027 Nashville Hematology Conference is intended for physicians, nurses, pharmacists, physician assistants, and other healthcare professionals who treat patients with hematologic malignancies.
The 2027 Nashville Hematology Conference (NHC 2027) will convene over 75 leading national experts, rising faculty, and community-based hematology clinicians for two days of CE-accredited education. Designed for practicing physicians and multidisciplinary oncology professionals, the conference addresses current standards, evolving treatment strategies, practical implementation challenges, and future directions across hematologic malignancies.
*Agenda is subject to change.
IDEOlogy Health’s 2-day CE-accredited conferences are carefully curated by top thought leaders and hosted at unique venues to create engaging and memorable learning experiences. Take a look at the upcoming conferences.
November 5-7, 2026
Austin, TX, at ACL Live at The Moody Theater
December 3-5, 2026
Nashville, TN, located at the Country Music Hall of Fame® and Museum
April 8-10, 2027
Austin, TX, at ACL Live at The Moody Theater